NeuroBo Pharmaceuticals EBITDA Margin 1970-1969 | MTVA
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for NeuroBo Pharmaceuticals (MTVA) over the last 10 years. The current EBITDA margin for NeuroBo Pharmaceuticals as of December 31, 1969 is .
| NeuroBo Pharmaceuticals EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.022B |
$0.000B |
|
NeuroBo Pharmaceuticals Inc. is a biopharmaceutical company. It is focused on novel treatments for neurodegenerative diseases. The company's novel lead candidate NB-01 is a drug candidate for diabetic neuropathic pain. NB-02 focuses on the treatment of neurodegenerative diseases. NeuroBo Pharmaceuticals Inc., formerly known as Gemphire Therapeutics Inc., is based in Northville, United States.
|
